Avoidance and Period-Shortening of Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer in Stages I and II: Importance of Ki-67 Labeling Index and the Recognition of Apocrine-Type Lesions.

Technology in Cancer Research & Treatment
Koichi KubouchiYutaka Tsutsumi

Abstract

Triple-negative breast cancer encompasses heterogeneous subtypes. Neoadjuvant chemotherapy is ineffective against some triple-negative breast cancers, while others show a favorable prognosis despite chemoresistance. A total of 51 cases with stages I and II triple-negative breast cancer were analyzed; 34 triple-negative breast cancers treated with neoadjuvant chemotherapy were divided into "good responders" (n = 22), showing therapeutic effect G2b or G3 in surgical specimens, and "poor responders" with therapeutic effect G0, G1a, G1b, and G2a (n = 12). Neoadjuvant chemotherapy was spared in 17 cases (non-neoadjuvant chemotherapy group). Apocrine-type triple-negative breast cancer was defined as triple-negative breast cancer immunoreactive for both androgen receptor and forkhead-box protein A1. Triple-negative breast cancer other than apocrine-type (n = 16) and special types (myoepithelial, medullary, adenoid cystic, and spindle cell carcinomas, n = 6) was categorized as basal-like subtype (n = 29). Prognosis was evaluated in each category. Neoadjuvant chemotherapy provoked significant effects against basal-like triple-negative breast cancer with high Ki-67 labeling (≧50%), and tumor-infiltrating lymphocytes predicted high chemos...Continue Reading

References

Jul 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B FisherN V Dimitrov
Aug 30, 2000·Nature·C M PerouD Botstein
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Therese SorlieDavid Botstein
Jul 9, 2003·The Breast Journal·Michelle SappWedad Hanna
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Torsten O NielsenCharles M Perou
Dec 13, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Chad A LivasyCharles M Perou
Jan 7, 2006·Molecular Endocrinology·Jason S Carroll, Myles Brown
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sunil BadveHarikrishna Nakshatri
Feb 6, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cornelia LiedtkeLajos Pusztai
Feb 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Priya RastogiNorman Wolmark
Oct 24, 2008·International Journal of Clinical Oncology·Yoshinari OgawaYukio Nishiguchi
Jun 25, 2009·Breast Cancer Research : BCR·André AlbergariaFernando Schmitt
Feb 19, 2010·The Cancer Journal·Ayca Gucalp, Tiffany A Traina
Nov 26, 2010·Virchows Archiv : an International Journal of Pathology·Minoru MiyashitaHironobu Sasano
Jun 3, 2011·The Journal of Clinical Investigation·Brian D LehmannJennifer A Pietenpol
Jun 28, 2011·The EMBO Journal·Jessica L L RobinsonJason S Carroll
Jul 26, 2011·Oncogene·M GuedjC Theillet
Oct 1, 2011·Journal of the National Cancer Institute·Mitch DowsettUNKNOWN International Ki-67 in Breast Cancer Working Group
Nov 26, 2011·Bioscience Reports·Gina M Bernardo, Ruth A Keri
Apr 21, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K GelmonS Verma
Jun 1, 2012·Frontiers in Endocrinology·Jessica L L Robinson, Jason S Carroll
Sep 18, 2012·The Journal of Steroid Biochemistry and Molecular Biology·K M McNamaraH Sasano
May 15, 2013·Breast Cancer Research : BCR·Jacqueline Lehmann-ChePhilippe Bertheau
Aug 10, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Aye Aye ThikePuay Hoon Tan
Aug 21, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroko MasudaNaoto T Ueno
Sep 21, 2013·Annals of Surgical Oncology·Lee J McGhanBarbara A Pockaj
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Nov 26, 2013·Journal of the National Cancer Institute·Francisco E Vera-BadilloEitan Amir
Jun 4, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Claudia Arce-SalinasEllen Warner
Jun 22, 2014·Endocrine-related Cancer·Keely M McNamaraWayne D Tilley
Aug 26, 2014·Annals of Surgical Oncology·Jung Eun ChoiYoung Kyung Bae
Sep 12, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Matthew D BursteinPowel H Brown

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

R

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.